Thimerosal News and Research

RSS

Environmental toxins may cause autism

The increase in the number of diagnosed cases of autism in recent years has sparked concern that environmental toxins may cause this complex disorder.

17 May 2007

CSL Biotherapies submits Biologics License Application to FDA

Pending approval of that application, CSL Biotherapies will introduce its influenza vaccine to the U.S. marketplace. The company's BLA requests that the vaccine be approved to immunize people 18 years of age and older.

3 Apr 2007

Vaccines again linked to form of autism

New findings presented yesterday at a National Autism Association meeting bolster claims that vaccines may play a role in the development of autism spectrum disorders.

8 Mar 2007

Thimerosal to be discussed at Wednesday's CDC meeting

The Advisory Committee on Immunization Practices (ACIP) will meet this week at the CDC in Atlanta. Thimerosal, a controversial mercury-based vaccine preservative, is scheduled to be discussed Wednesday morning at 10:55 am.

19 Feb 2007

FDA approves MedImmune's new refrigerated formulation of FluMist influenza virus vaccine

MedImmune has announced that the U.S. Food and Drug Administration (FDA) has approved the company's new refrigerated formulation of FluMist (Influenza Virus Vaccine Live, Intranasal) for use in helping to prevent influenza in healthy children and adults from 5 years to 49 years of age.

8 Jan 2007

FDA approves FluLaval

The U.S. Food and Drug Administration (FDA) today approved FluLaval, an influenza vaccine to immunize people 18 years of age and older against the disease caused by strains of influenza virus judged likely to cause seasonal flu in the Northern Hemisphere in 2006-2007.

5 Oct 2006

Fombonne's autism research is dangerously inaccurate

Fombonne, a thimerosal litigation expert witness on behalf of various pharmaceutical companies, will reportedly state that it is "very clear" there is no relationship between mercury-based thimerosal and the onset of autism.

11 Jul 2006

First evidence that dendritic cells show unprecedented sensitivity to thimerosal

A team of cell biologists, toxicologists and molecular bioscientists at UC Davis has published a study connecting thimerosal with disruptions in antigen-presenting cells known as dendritic cells obtained from mice.

22 Mar 2006

Study reveals most common causes of allergic contact dermatitis

A new Mayo Clinic study reveals the most common causes of allergic contact dermatitis, a skin inflammation resulting in swollen, reddened and itchy skin due to direct contact with an allergen.

7 Mar 2006

Steady upward climb in child vaccinations

According to U.S. health officials, a record high rate of 81 percent of toddlers 19 months to 3 years old are now getting vaccinated with the full recommended series.

27 Jul 2005

Debate on autism link to vaccines fired up again

In a relatively unusual event, federal health officials called a news conference this week in an attempt to affirm the safety of vaccines.

21 Jul 2005

Intestinal hormone secretin should not be used to treat autism

The intestinal hormone secretin, considered by some to be a promising drug in the treatment of autism, does not improve the symptoms and should not be used to treat the disorder, according to a new review of studies.

19 Jul 2005

New flu vaccine for kids hits the market

A new pediatric influenza vaccine that contains no preservatives - the only influenza vaccine approved for use in children 6 to 35 months of age - has been produced by the sanofi-aventis Group, in time for the 2005-2006 influenza season.

10 Mar 2005

No discernible link between the three-in-one vaccine and child behavioural problems

A new study of children’s behaviour problems has come to the conclusion that there is no discernible link with the three-in-one vaccine now being phased out in the UK.

8 Sep 2004

Drug company fights to keep toxin in vaccines

The UK announced Saturday they will remove the mercury preservative Thimerosal from their vaccines. The news comes days after an LA Times article reported that Aventis-Pasteur, a pharmaceutical giant, is pushing to keep the toxin in U.S. vaccines.

13 Aug 2004

Postnatal exposure to a mercury preservative commonly used in a number of childhood vaccines can lead to the development of autism-like damage

A new study published online June 8 in the Nature publication, Molecular Psychiatry, indicates that postnatal exposure to thimerosal, a mercury preservative commonly used in a number of childhood vaccines, can lead to the development of autism-like damage in autoimmune disease susceptible mice

11 Jun 2004

Collusion seen after release of flawed vaccine-autism report

America's leading scientific organization investigating the risks that mercury-containing medical products pose to our children-has posted the results of an investigative analysis of several authors relied upon for the flawed Institute of Medicine (IOM) report issued last week attempting to purport a lack of evidence to the mercury-vaccine-autism link.

25 May 2004

Suspension of the initial dose of hepatitis B vaccine appears to have contributed to fewer newborns being vaccinated in 2000

A temporary suspension of the initial dose of hepatitis B vaccine appears to have contributed to fewer newborns being vaccinated for hepatitis B in 2000 than in 1998, according to a study published in the May 19 issue of the Journal of the American Medical Association (JAMA).

22 May 2004

Report rejects childhood vaccines as a cause of autism

A pivotal report issued today by the Institute of Medicine (IOM) rejects childhood vaccines as a cause of autism. The findings, based on reviews of current scientific evidence, are a significant affirmation of vaccine safety, according to the American Academy of Pediatrics (AAP).

19 May 2004

Autism Associations shows CDC and FDA to be negligent

National Autism Association announced Tuesday that the Centers for Disease Control (CDC), Food and Drug Administration (FDA) and some pharmaceutical companies have become a target for investigation.

14 Apr 2004